Hour24 News
Sophisticated and simple
-
Breakthrough in bacterial immunotherapy: ACTM-838 targets solid tumors Solid tumors have long posed a challenge for immunotherapy, often creating an immune-suppressive microenvironment that thwarts even…
-
A breakthrough design for solid tumors: CAR T cells deliver IL-12 and PD-L1 blocker Chimeric antigen receptor (CAR) T cell therapy has transformed treatments for…
